Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/25/24 16:05 | 7/23/24 | SGMT | Health | Drug | Pharmaceutical Preparations | Kemble George | CA | DO | Exec CB | S | -75 | 3.17 | 0 | -24 | -17 | 119 | D | ||||||||||||||
7/23/24 16:06 | 7/19/24 | SGMT | Health | Drug | Pharmaceutical Preparations | Martins Eduardo Bruno | CA | O | Chief Me | S | -26 | 3.10 | 0 | -8 | -9 | 81 | D | ||||||||||||||
7/23/24 16:05 | 7/19/24 | SGMT | Health | Drug | Pharmaceutical Preparations | Rozek Elizabeth | CA | O | GC,CCO | S | -34 | 3.10 | 0 | -11 | -6 | 161 | D | ||||||||||||||
7/23/24 16:05 | 7/19/24 | SGMT | Health | Drug | Pharmaceutical Preparations | Kemble George | CA | DO | Exec CB | S | -44 | 3.10 | 0 | -14 | -9 | 142 | D | ||||||||||||||
7/20/23 18:56 | 7/18/23 | SGMT | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | S.d | -11 | 16.00 | 0 | -1 | 0 | 3,850 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |